Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Elicio Therapeutics (ELTX) Asset Utilization Ratio (2021 - 2023)

Elicio Therapeutics filings provide 3 years of Asset Utilization Ratio readings, the most recent being 0.02 for Q1 2023.

  • On a quarterly basis, Asset Utilization Ratio fell 93.74% to 0.02 in Q1 2023 year-over-year; TTM through Mar 2023 was 0.02, a 93.74% decrease, with the full-year FY2022 number at 0.04, down 89.9% from a year prior.
  • Asset Utilization Ratio hit 0.02 in Q1 2023 for Elicio Therapeutics, down from 0.05 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.42 in Q3 2022 to a low of 0.0 in Q2 2021.
  • Median Asset Utilization Ratio over the past 3 years was 0.05 (2022), compared with a mean of 0.16.
  • Biggest five-year swings in Asset Utilization Ratio: surged 34066.99% in 2022 and later crashed 93.74% in 2023.
  • Elicio Therapeutics' Asset Utilization Ratio stood at 0.27 in 2021, then crashed by 79.43% to 0.05 in 2022, then plummeted by 63.01% to 0.02 in 2023.
  • The last three reported values for Asset Utilization Ratio were 0.02 (Q1 2023), 0.05 (Q4 2022), and 0.42 (Q3 2022) per Business Quant data.